These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23489981)

  • 1. Cost effectiveness of high resolution computed tomography with interferon-gamma release assay for tuberculosis contact investigation.
    Kowada A
    Eur J Radiol; 2013 Aug; 82(8):1353-8. PubMed ID: 23489981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of the interferon-γ release assay for tuberculosis screening of hemodialysis patients.
    Kowada A
    Nephrol Dial Transplant; 2013 Mar; 28(3):682-8. PubMed ID: 23239835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries.
    Kowada A; Takasaki J; Kobayashi N
    J Hosp Infect; 2015 Feb; 89(2):99-108. PubMed ID: 25559158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of interferon-γ release assay versus chest X-ray for tuberculosis screening of employees.
    Kowada A
    Am J Infect Control; 2011 Dec; 39(10):e67-72. PubMed ID: 21839543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of interferon-gamma release assay for school-based tuberculosis screening.
    Kowada A
    Mol Diagn Ther; 2012 Jun; 16(3):181-90. PubMed ID: 22594558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of interferon-γ release assay for TB screening of HIV positive pregnant women in low TB incidence countries.
    Kowada A
    J Infect; 2014 Jan; 68(1):32-42. PubMed ID: 23973660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of interferon-gamma release assay for tuberculosis screening using three months of rifapentine and isoniazid among long-term expatriates from low to high incidence countries.
    Kowada A
    Travel Med Infect Dis; 2016; 14(5):489-498. PubMed ID: 27238907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.
    de Perio MA; Tsevat J; Roselle GA; Kralovic SM; Eckman MH
    Arch Intern Med; 2009 Jan; 169(2):179-87. PubMed ID: 19171815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-optimisation of screening for latent tuberculosis in close contacts.
    Diel R; Nienhaus A; Lange C; Schaberg T
    Eur Respir J; 2006 Jul; 28(1):35-44. PubMed ID: 16571615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of tobacco cessation support combined with tuberculosis screening among contacts who smoke.
    Kowada A
    Int J Tuberc Lung Dis; 2015 Jul; 19(7):857-63. PubMed ID: 26056114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.
    Oxlade O; Schwartzman K; Menzies D
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):16-26. PubMed ID: 17217125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of interferon-gamma release assay for tuberculosis contact screening in Japan.
    Kowada A; Takahashi O; Shimbo T; Ohde S; Tokuda Y; Fukui T
    Mol Diagn Ther; 2008; 12(4):235-51. PubMed ID: 18652520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of Quantiferon®-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil.
    Steffen RE; Caetano R; Pinto M; Chaves D; Ferrari R; Bastos M; de Abreu ST; Menzies D; Trajman A
    PLoS One; 2013; 8(4):e59546. PubMed ID: 23593145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of interferon-gamma release assay versus chest X-ray for tuberculosis screening of BCG-vaccinated elderly populations.
    Kowada A; Deshpande GA; Takahashi O; Shimbo T; Fukui T
    Mol Diagn Ther; 2010 Aug; 14(4):229-36. PubMed ID: 20799765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries.
    Hardy AB; Varma R; Collyns T; Moffitt SJ; Mullarkey C; Watson JP
    Thorax; 2010 Feb; 65(2):178-80. PubMed ID: 19996345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts.
    Marra F; Marra CA; Sadatsafavi M; Morán-Mendoza O; Cook V; Elwood RK; Morshed M; Brunham RC; Fitzgerald JM
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1414-24. PubMed ID: 19017451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection.
    Deuffic-Burban S; Atsou K; Viget N; Melliez H; Bouvet E; Yazdanpanah Y
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):471-81. PubMed ID: 20202306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tuberculosis Contact Investigation: Eight Years of Experience with the QuantiFERON-TB®Gold In-Tube in Lower Saxony, Germany].
    Scharlach M; Brakensiek K
    Gesundheitswesen; 2017 Apr; 79(4):273-278. PubMed ID: 27855476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of interferon-gamma release assays for tuberculosis screening in nursing homes.
    Kowada A
    Epidemiol Infect; 2016 Nov; 144(15):3215-3225. PubMed ID: 27412626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of contact screening strategies for tuberculosis among high-school adolescents in South Korea.
    Sohn H; Kim HY; Lee SH
    Int J Tuberc Lung Dis; 2018 May; 22(5):496-503. PubMed ID: 29663953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.